Clinical Course of Unilateral Moyamoya Disease.

Ephraim W ChurchTeresa E Bell-StephensMark G BigderSantosh GummidipundiSummer S HanGary K Steinberg

Published in: Neurosurgery (2022)

Previous series showed relatively high rates of progression in unilateral MMD (15%-30%), but these studies were small and long-term follow-up was rarely available. Our large series indicates that the rate of progression is lower than previously reported but still warrants yearly noninvasive screening. These data may provide indirect support for statin therapy in MMD.

Keyphrases

cardiovascular disease
electronic health record
coronary artery disease
middle cerebral artery
stem cells
case control
type diabetes
machine learning
mesenchymal stem cells
deep learning
low density lipoprotein